<DOC>
	<DOCNO>NCT02447848</DOCNO>
	<brief_summary>To evaluate safety efficacy sufentanil tablet ( ST ) 30 mcg management moderate-to-severe acute pain patient emergency room ( ER ) setting .</brief_summary>
	<brief_title>A Multicenter , Open-Label Trial Evaluate Safety Efficacy Sublingual Sufentanil Tablet 30 mcg Treatment Acute Pain</brief_title>
	<detailed_description>The study multicenter , open-label trial , patient 18 year old , present ER moderate-to-severe acute pain due obvious trauma injury evident physical examination . Upon meet entrance criterion , patient administer four dos sufentanil 30 mcg remain study 5 hour safety efficacy measurement . Safety monitor via periodic measurement vital sign continuous monitor oxygen saturation , well assessment adverse event ( AEs ) use concomitant medication . Efficacy assess patient report pain intensity ( PI ) pain relief . A Six-Item Screener ( SIS ) administer 1 hour study drug administration measure cognitive impairment . The Patient Global Assessment ( PGA ) Healthcare Professional Global Assessment ( HPGA ) ass global satisfaction method pain control .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Patients present ER moderatetosevere pain due obvious trauma injury evident physical examination . Patients classified American Society Anesthesiologists ( ASA ) class IIII Patients willing capable understanding cooperating requirement study . Patients able understand communicate English . Patients provide write informed consent sign IRB approve consent form . Patients take opioid 30 consecutive day , daily dose 15 mg morphine ( equivalent ) , within past 3 month ( e.g . 3 dos per day Vicodin® , Norco® , Lortab® 5 mg hydrocodone per tablet ) . Patients use illicit drug abuse , abuse prescription medication alcohol ( 4 drink per day ) within one year start study . Patients allergy hypersensitivity opioids . Patients currently take monoamine oxidase inhibitor ( MAOIs ) take MAOIs within 14 day dose study drug . Patients current sleep apnea document sleep laboratory study home continuous positive airway pressure ( CPAP ) . Female patient pregnant ( positive pregnancy test ) breastfeeding . Patients medical condition , Investigator 's opinion , could adversely impact patient 's participation safety , conduct study , interfere pain assessment , include chronic pain active infection . Patients present ER use supplemental oxygen . Patients participate clinical trial investigational drug device within 30 day enrollment . Patients active reserve duty US military .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>